728 filings
Page 2 of 37
SC 13G
Armistice Capital, LLC
14 Feb 24
KINETA / ARMISTICE CAPITAL ownership change
3:40pm
SC 13D/A
Shawn Iadonato
12 Feb 24
KINETA / Iadonato Shawn ownership change
4:05pm
SC 13G/A
Magness Charles
12 Feb 24
KINETA / Magness Charles ownership change
4:05pm
8-K
KA
Kineta Inc
17 Jan 24
Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors
8:30am
8-K
KA
Kineta Inc
5 Jan 24
Regulation FD Disclosure
4:30pm
8-K
KA
Kineta Inc
15 Dec 23
Entry into a Material Definitive Agreement
8:30am
4
Raymond J. Bartoszek
6 Dec 23
KINETA / Raymond J. Bartoszek ownership change
6:21pm
4
KA
Kineta Inc
30 Nov 23
KINETA / CRAIG W. PHILIPS ownership change
5:27pm
4
Shawn Iadonato
30 Nov 23
KINETA / Shawn Iadonato ownership change
5:21pm
EFFECT
KA
Kineta Inc
15 Nov 23
Notice of effectiveness
12:15am
424B3
KA
Kineta Inc
13 Nov 23
Prospectus supplement
5:28pm
CORRESP
KA
Kineta Inc
9 Nov 23
Correspondence with SEC
12:00am
UPLOAD
KA
Kineta Inc
9 Nov 23
Letter from SEC
12:00am
8-K
KA
Kineta Inc
6 Nov 23
Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
8:30am
S-3
KA
Kineta Inc
Shelf registration
3 Nov 23
4:25pm
10-Q
2023 Q3
KA
Kineta Inc
Quarterly report
3 Nov 23
4:04pm
8-K
KA
Kineta Inc
3 Nov 23
Kineta Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:02pm
8-K
KA
Kineta Inc
3 Nov 23
Kineta Presents New Preclinical Data on Lead Anti-CD27 Monoclonal Antibody at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
4:01pm
D
KA
Kineta Inc
20 Oct 23
$2.89 mm in options / securities to be acquired, 1 investor
1:04pm
8-K
KA
Kineta Inc
17 Oct 23
Entry into a Material Definitive Agreement
8:32am